Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Oct 3 - Oct 8
Its two RLT products Lutathera (lutetium-177 DOTATATE) for gastroenteropancreatic neuroendocrine tumours (GEP-NETs) and Pluvicto (lutetium-177 PSMA-617) for metastatic castration-resistant prostate cancer represent the most commercially advanced radioligand therapy platform in the world and occupy the Oncology Peptide Therapy segment, which the report forecasts to grow at 11.79% CAGR through 2031
When a compound has such a narrow target, the potential for off-target side effects is inherently limited
Discard the vial when its expiration or recommended in-use period is reached
Some online medical supply stores sell it, but regulations and availability vary by region
1 (Springer, 2014)
Microscopic analysis revealed increased capillary density, improved vessel maturation, and enhanced blood flow in BPC-157 treated wounds
US$ 24.59
US$ 27.83
US$ 23.33
US$ 26.38
